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Introduction
Functional blood vessels are of vital importance. Impaired vessel 
formation contributes to many pathological situations, including 
ischemic and inflammatory disorders. Ischemic retinopathies 
are the main causes of severe visual impairment and sight loss in 
premature children, diabetic adults, and the elderly population. 
In particular, retinopathy of prematurity (ROP), a developmental 
ocular neovascular disease and the major cause of acquired blind-
ness in preterm infants (1), is characterized by excessive angiogen-
esis, breakdown of the endothelial barrier, vascular leakage, edema, 
hemorrhages, retinal detachment, and compromised vision (1). 
Although certain strategies to block excessive angiogenesis exist 
(2), identification of other pathways that regulate physiological 
and pathological vessel growth is of high interest in order to fur-
ther develop better or complementary therapeutic treatments.
The formation of functional blood vessel networks starts with 
the initial formation of a primitive vascular plexus from which new 
blood vessels sprout, coordinately expand, and branch. Redun-
dant vessel branches are then selectively removed by vessel prun-
ing to ultimately establish a hierarchical vascular network (3, 4). 
Whereas apoptosis has been implicated in certain conditions of 
vessel remodeling (5–9) and in the regulation of capillary vessel 
diameter (10), it is not known whether other forms of cell death 
contribute to developmental angiogenesis or whether cell death 
signaling molecules have cell death–independent functions in 
endothelial cells (ECs).
Caspase-8 (Casp-8) is the initiator caspase of the extrinsic 
apoptosis pathway that activates the effector caspase-3 (11). Cel-
lular FLICE inhibitory protein (c-FLIP), an inactive homolog of 
Casp-8 that lacks its catalytic activity, can heterodimerize with 
Casp-8, prevent its full activation, and thus inhibit apoptosis (11). 
The c-FLIP/Casp-8 heterodimer still possesses a basal Casp-8 
activity necessary to inhibit a second type of programmed cell 
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Figure 1, A and B; supplemental material available online with this 
article; https://doi.org/10.1172/JCI122767DS1).
To analyze the effect of loss of Casp-8 in ECs during postnatal 
vascular development, we induced Cre recombination in newborn 
pups, as previously described (ref. 25 and Figure 1A), and checked 
the recombination efficiency in isolated lung ECs (Supplemental 
Figure 1, C and D). Tamoxifen treatment resulted in 70% reduc-
tion of Casp-8 mRNA levels in lung ECs from Casp-8ECKO pups 
at P6 (Supplemental Figure 1D). In contrast to the lethal effects 
of loss of Casp-8 in the embryonic vasculature, postnatal KO of 
Casp-8 was not lethal during the time the mice were observed 
(until P15) and pups were indistinguishable from Casp-8WT litter-
mates (Supplemental Figure 1, E–G). As Casp-8 is expressed in 
ECs of developing blood vessels in the retina (Supplemental Fig-
ure 1H) and as this is a well-established model to postnatally study 
developmental angiogenesis (26), we used the growing retina for 
our purposes. Analysis of the vasculature (by staining with the 
endothelial marker isolectin B4 [IsoB4]) in P6 retinas showed that 
the total area covered by blood vessels and the vascular outgrowth 
were reduced in Casp-8ECKO retinas compared with that in Casp-
8WT littermates (Figure 1, B–D). The number of vessel branches 
was also decreased (Figure 1, E and F), indicating a reduced com-
plexity of the vascular network in Casp-8ECKO pups. In addition, we 
counted fewer sprouts at the angiogenic front in Casp-8ECKO pups 
(Figure 1, G and H). Together, these data show that loss of Casp-8 
in the endothelium results in vascular defects during develop-
mental angiogenesis.
Necroptosis does not contribute to the vascular defects in Casp-8ECKO 
pups. During postnatal angiogenesis in the retina, the vascular 
network develops to its final mature stage via a combination of 
different cellular processes, such as EC proliferation, migration, 
vessel maturation, and vessel remodeling. As Casp-8 regulates 
cell death and survival and as this contributes to vessel remodel-
ing and regression (5, 8, 9), we checked to determine whether KO 
of Casp-8 would result in EC death due to activation of the necro-
ptotic pathway. In vivo, an indirect way to assess cell death is the 
quantification of regressing vessel branches, which leave collagen 
type IV (ColIV+) empty sleeves behind (27). Therefore, we ana-
lyzed vessel regression by quantifying the number of CollV+IsoB4– 
sleeves and found no differences between genotypes (Figure 2, A 
and B). In line with these results, pericyte coverage analyzed by 
costaining of the pericyte marker desmin and IsoB4 revealed no 
differences between Casp-8ECKO and Casp-8WT retinas, indicating 
that vessel maturation and stabilization were also not affected 
(Figure 2, C and D). Interestingly, we noticed a small but signifi-
cant decrease in the number of cleaved caspase-3+ (cCasp-3+) and 
TUNEL+ ECs in Casp-8ECKO pups (Figure 2, E–H), suggesting that 
Casp-8–mediated apoptosis via the extrinsic cell death signaling 
pathway may have a small but significant contribution to the phys-
iological remodeling process, without, however, affecting overall 
vessel regression. To further explore this hypothesis, we first ana-
lyzed the ability of ECs to die by necroptosis in vitro. For this pur-
pose, we counted the number of propidium iodide–positive (PI+) 
cells (PI detects apoptotic and necroptotic cells; ref. 28) in WT 
(Casp-8WT) and Casp-8–knockdown (Casp-8KD) HUVECs using a 
lentivirus–mediated shRNA KD system (ref. 29 and Supplemental 
Figure 2A). Both Casp-8WT and Casp-8KD HUVECs showed a slight, 
death, called necroptosis (a nonapoptotic cell death characterized 
by swelling and rupture of the cell membrane) (12, 13). To do so, 
Casp-8 cleaves the receptor-interacting serine/threonine protein 
kinase 3 (RIPK3) and therefore blocks the activation of the ulti-
mate effector of necroptosis, the pseudokinase mixed-lineage 
kinase domain-like (MLKL), downstream of RIPK3 (13). There-
fore, Casp-8 is a central signaling node in the determination of 
whether a particular cell dies by apoptosis or necroptosis. In addi-
tion to its role in cell death signaling, Casp-8 has been described as 
regulating cell death–independent processes, such as cell migra-
tion (14, 15) or proliferation (16), and acting as DNA-damage sen-
sor induced by cell proliferation (17).
Deletion of Casp-8 in mice is embryonically lethal. Interest-
ingly, Casp-8–KO mouse embryos die at midgestation, present-
ing a circulatory failure phenotype and damaged blood vessel 
capillaries (18–20). EC-specific KO of Casp-8 during embryonic 
development mimics the severity of the full KO (21), suggesting 
that Casp-8 in ECs is required for the formation of a proper vas-
cular system. However, whether Casp-8 is also required at later 
time points during vessel development and whether it plays a cell 
death–dependent or –independent function remain unknown.
In this regard, cell death–dependent and –independent func-
tions of RIPK3 have been described in pathological angiogenesis. 
In a mouse model of melanoma metastasis, it has been shown 
that RIPK3 is involved in tumor-induced EC necroptosis, but 
also in vessel permeability via activation of p38 (22, 23). Whether 
RIPK3 not only contributes to pathological vessel formation and 
function, but also to vessel stability in physiological conditions of 
angiogenesis, is so far unknown.
Here, using a conditional inducible EC–specific Casp-8–KO 
mouse line (Casp-8ECKO), we show that the loss of Casp-8 results in 
reduced postnatal retina angiogenesis. Most strikingly, we demon-
strate that this phenotype is independent of necroptosis, as the 
loss of Casp-8 on a MLKL-null background still results in vascular 
defects. Instead, Casp-8 regulates EC proliferation, sprouting, and 
migration as well as the stability of adherens and tight junctions. 
Mechanistically, we show that loss of Casp-8 leads to the constitu-
tive phosphorylation of p38 MAPK via RIPK3 and to defects in vas-
cular endothelial cadherin (VE-cadherin) subcellular localization. 
Applying the oxygen-induced retinopathy (OIR) model, a model 
that resembles the pathology of ROP, we show that the loss of 
Casp-8 in ECs is beneficial during this developmental neovascular 
eye disease, as pathological neovascularization in Casp-8ECKO mice 
is reduced.
Results
Postnatal deletion of Casp-8 in ECs results in impaired angiogenesis in 
the retina. To explore the function of Casp-8 during developmental 
angiogenesis in vivo, we generated inducible EC-specific Casp-8–
KO mice. To do so, we crossed the tamoxifen-inducible Cdh5-
(PAC)-CreERT2 mouse line (24), in which Cre-recombinase is 
expressed under control of the EC-specific Cdh-5 promoter, with 
Casp-8fl/fl mice. Consistent with previously published data (21), 
therefore validating our generated mouse line, KO of Casp-8 in 
the endothelium during embryonic development resulted in yolk 
sac and embryo vascular defects as well as in increased embryonic 
lethality and defects in the yolk sac vasculature (Supplemental 
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ing that blocking necroptosis in Casp-8ECKO pups did not rescue 
the vascular defects.
Our data indicate that the loss of Casp-8 in ECs during postna-
tal development does not induce cell death via necroptosis. Even 
though we found a mild decrease in the number of cCasp-3+ and 
TUNEL+ ECs at P6 in Casp-8ECKO pups, this did not affect the per-
centage of vessel regression overall, indicating that extrinsic cell 
death is not an active driver of vessel pruning during postnatal vas-
cular development. Our data further suggest that Casp-8 regulates 
developmental angiogenesis in a cell death–independent way.
Casp-8 regulates VEGF-induced EC sprouting, proliferation, and 
migration. It has been shown that Casp-8 has diverse cell death–
independent functions, for example, in the regulation of cell migra-
tion (14, 32). Thus, to further characterize the EC phenotype and 
to understand which processes are impaired upon loss of Casp-8, 
we analyzed the response of Casp-8KD ECs upon VEGF stimula-
tion. To do so, we analyzed EC sprouting in vitro using the bead 
sprouting assay (33). While KD of Casp-8 (using a specific siRNA, 
Supplemental Figure 4A) had no effect on unstimulated condi-
tions, Casp-8KD ECs failed to respond to VEGF stimulation (Fig-
ure 3, A and B). Additionally, we tested the response of Casp-8KD 
ECs to VEGF stimulation using the tube-formation assay. 
though not significant, increase in the number of PI+ cells upon 
TRAIL or TNF stimulation (Supplemental Figure 2B). As a positive 
control to demonstrate that HUVECs were not just resistant to cell 
death, we knocked down c-FLIP (c-FLIPKD), the intrinsic inhibitor 
of Casp-8. c-FLIPKD ECs presented a significant increase in cell 
death upon TNF or TRAIL stimulation (Supplemental Figure 2B). 
As vessel development in the retina is regulated by hypoxia (30) 
and hypoxia can be a modulator of cell death (31), we also per-
formed the same experiments under hypoxic conditions, which 
produced the same results (Supplemental Figure 2C).
Finally, to determine whether necroptosis could contrib-
ute to the observed phenotype in vivo, we genetically delet-
ed MLKL (the ultimate effector of necroptosis; ref. 13) in the 
Casp-8ECKO mice by crossing Cdh5-(PAC)-CreERT2 × Casp-8fl/fl 
mice with a MLKLKO mouse line. The vessel area and the num-
ber of vessel branches at P6 were not affected in heterozygous 
or homozygous MLKLKO pups compared with WT littermates 
(Supplemental Figure 3, A–D), indicating that MLKL alone did 
not contribute to angiogenesis. However, the vessel area and 
the number of vessel branches as well as the sprouts at the 
angiogenic front were still reduced in Casp-8ECKO/MLKLKO pups 
(compared with Casp-8WT/MLKLKO pups) (Figure 2, I–M), show-
Figure 1. Postnatal EC-specific KO of Casp-8 results in impaired angiogenesis. (A) Schematic showing tamoxifen administration in pups. (B) Representa-
tive images of whole-mount P6 retinas stained with IsoB4 (ECs) in Casp-8WT and Casp-8ECKO mice. Dashed black lines highlight the total retina area. (C and 
D) Quantification of vessel area (C; n = 22 WT, n = 21 ECKO) and retina vessel outgrowth (D; n = 20 WT, n = 20 ECKO). (E) Representative higher magnifica-
tions of the retina stained with IsoB4. (F) Quantification of number of branches (n = 18 WT, n = 16 ECKO). (G) Representative images of the retina angio-
genic front stained with IsoB4. Black arrows point to EC sprouts. (H) Quantification of the number of sprouts per front length showing reduced number 
of sprouts in Casp-8ECKO retinas (n = 16 WT, n = 12 ECKO). For C, D, F, and H, data are shown as mean ± SEM from 4 independent litters. *P < 0.05; ***P < 
0.001, 2-tailed unpaired Student’s t test. Scale bars: 100 μm (B); 50 μm (E); 20 μm (G).
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Figure 2. Loss of Casp-8 in ECs does not result in vessel regression or necroptosis. (A) Retinas from P6 pups were costained with IsoB4 and collagen IV 
(ColIV) in Casp-8WT and Casp-8ECKO retinas. White arrows point to ColIV+IsoB4– empty sleeves. (B) Quantification of relative vessel regression shows no 
significant differences between genotypes (n = 19 WT, n = 11 ECKO). (C) Representative images of pericyte coverage. Retinas were costained with desmin 
(pericyte marker) and IsoB4. (D) Quantification of Desmin+ area per vascular area (%) shows no significant differences between genotypes (n = 12 WT, n = 8 
ECKO). (E) Representative images of apoptotic ECs (white arrows), costained with IsoB4 and cCasp-3. (F) Quantification of cCasp-3+IsoB4+ cells per vessel 
area revealing fewer apoptotic ECs in Casp-8ECKO retinas compared with Casp-8WT (n = 6 WT, n = 7 ECKO). (G) Representative images of retinas costained 
with IsoB4 and TUNEL (black arrows point to TUNEL+ ECs). Images showing IsoB4 were transformed to gray colors with ImageJ for better visualization. 
(H) Quantification of relative amount of TUNEL+ ECs per vessel area also shows decreased numbers of apoptotic ECs in Casp-8ECKO retinas (n = 15 WT, n 
= 10 ECKO). (I and J) Representative images of the retinal vasculature stained with IsoB4 in Casp-8WT/MLKLKO and Casp-8ECKO/MLKLKO mice. Black arrows 
point to EC sprouts. (K–M) Quantitative analysis showing reduced vessel area (K; n = 11 WT, n = 11 ECKO), number of branches (L; n = 6 WT, n = 8 ECKO), and 
reduced number of sprouts per front area (M; n = 6 WT, n = 8 ECKO) in Casp-8ECKO/MLKLKO retinas compared with Casp-8WT/MLKLKO littermates. For B, D, F, 
H, and K–M, data are shown as mean ± SEM from at least 3 independent litters. *P < 0.05, 2-tailed unpaired Student’s t test. Scale bars: 100 μm (A, C, and 
I); 20 μm (E and G); 50 μm (J).
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cent Glo assay, we first confirmed that ECs have a basal Casp-8 
activity, which could be blocked with the Casp-8 inhibitor Z-IETD-
FMK (ZIETD, Supplemental Figure 4D). As a positive control for 
our assay, we treated ECs with a combination of cycloheximide 
(CHX) and TNF to induce apoptosis, which strongly increased 
Consistently, the ability of Casp-8KD ECs to form capillary-like 
tube structures upon VEGF stimulation was also significantly 
attenuated (Supplemental Figure 4, B and C).
We next determined whether Casp-8 activity was required for 
the proper response of ECs to VEGF stimulation. Using a lumines-
Figure 3. Loss of Casp-8 in ECs impairs sprouting, proliferation, and migration. (A) Representative images of the bead-sprouting assay using HUVECs transfected 
with control siRNA (siCtrl) or Casp-8 siRNA (siCasp-8) and treated with VEGF (50 ng/ml) for 24 hours. (B) Quantitative analysis of total sprout length showing that 
VEGF is not able to induce vessel sprouting in the absence of Casp-8. Approximately 20 beads per condition were quantified. n = 4. (C) Representative images of 
the retinal vasculature costained with IsoB4, EdU (labels proliferating cells), and ERG (labels EC nuclei) in Casp-8WT and Casp-8ECKO mice. IsoB4 single channel was 
transformed to gray colors and inverted with ImageJ for better visualization. (D and E) Masks obtained by ImageJ of ERG+ cells (D) and of ERG+ EdU+ proliferating 
ECs (E). (F and G) Quantification of total number of ECs per retina area (F; n = 7 WT, n = 12 ECKO) and proliferating ECs per vessel area (G; n = 4 WT, n = 7 ECKO), 
revealing lower absolute EC numbers and fewer proliferating ECs in Casp-8ECKO retinas compared with Casp-8WT littermates. Data from 2 independent litters. (H) 
Single-cell motility tracks of HUVECs infected with a control (shCtrl) or Casp-8 shRNA lentivirus (shCasp-8) and treated with VEGF (50 ng/ml) for 12 hours. Migra-
tion origin of each cell was overlaid at the zero-crossing point. (I) Quantification of the total migration distance of HUVECs in H showing that VEGF-induced migra-
tion was impaired in Casp-8KD ECs. At least 30 cells per condition were quantified. n = 3. For B, F, G, and I, data are shown as mean ± SEM. *P < 0.05; ***P < 0.001, 
2-way ANOVA with Bonferroni’s multiple comparisons test (B and I); *P < 0.05, 2-tailed unpaired Student’s t test (F and G). Scale bars: 200 μm (A); 50 μm (C).
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Casp-8 activity, as expected (Supplemental Figure 4D). Function-
ally, blocking Casp-8 activity in ECs resulted in the same defects 
as the KD of Casp-8, as ZIETD-treated ECs did not form sprouts 
upon VEGF stimulation (Supplemental Figure 4, E and F), indicat-
ing that Casp-8 activity was required for proper angiogenesis.
To assess whether changes in EC proliferation could con-
tribute to the reduced vascular area in Casp-8ECKO retinas, we 
performed proliferation experiments. shRNA-mediated Casp-8 
KD in HUVECs resulted in reduced proliferation upon stimula-
tion with VEGF or FGF, as determined by BrdU incorporation 
(Supplemental Figure 4G). Also, siRNA-transfected Casp-8KD 
HUVECs had a reduced response to VEGF stimulation in the 
WST-1 cell proliferation and viability assay (Supplemental Fig-
ure 4H). In vivo, the total number of ECs, as determined by 
counting ERG+ nuclei per retina area (ERG is an EC-specific 
transcription factor; ref. 34) was reduced (Figure 3, C, D, and F). 
EdU labeling of proliferating cells in P6 retinas showed signifi-
cantly fewer EdU+ERG+ cells per vessel area in Casp-8ECKO pups 
compared with Casp-8WT littermates (Figure 3, C, E, and G), 
indicating that reduced EC proliferation could account for the 
reduced vessel area.
EC migration is also required for proper expansion of the 
vascular network. We therefore checked to determine whether 
KD of Casp-8 in ECs could also affect this process. In a classical 
scratch-wound assay, VEGF stimulation of Casp-8WT ECs led to 
almost 80% closure of the wound, whereas KD of Casp-8 reduced 
VEGF-induced wound closure (Supplemental Figure 4, I and J). 
To determine whether Casp-8 affected migration independently 
of its effects on proliferation, we performed live-imaging experi-
ments and tracked the movement of nondividing single Casp-8KD 
ECs. Indeed, the total migration distance of ECs after 12 hours 
of VEGF stimulation was reduced when Casp-8 was knocked 
down (Figure 3, H and I). Together, these results show that Casp-
8 regulates EC proliferation and migration, which contributes to 
VEGF-induced sprouting.
Loss of Casp-8 affects the organization of adherens and tight junc-
tions in ECs. Aside from being important for vascular homeosta-
sis and vessel stability, dynamic turnover of vascular endothelial 
cadherin (VE-cadherin) is crucial for proper vessel sprouting and 
elongation during angiogenesis (35–39).
As both sprouting and migration were impaired in Casp-8ECKO 
mice and as Casp-8 has been shown to regulate the stability of cell 
junctions in the epidermis (40), we analyzed the distribution of 
VE-cadherin in vivo in the sprouting front and in the plexus of the 
growing vasculature of P6 retinas. By using an established image 
software analysis and classification key (35, 41), we distinguished 
Figure 4. Casp-8 is necessary for 
maintaining EC junction stability 
at the retina plexus in vivo. (A) Repre-
sentative images of Casp-8WT and 
Casp-8ECKO retinas stained with IsoB4, 
VE-cadherin, and claudin-5 (insets of 
left panels are shown on the adjacent 
right panels), showing that junctions 
are more serrated and discontinuous 
at the retina plexus in Casp-8ECKO 
compared with Casp-8WT mice (yellow 
arrows). Images of VE-cadherin and 
Claudin-5 single channels were trans-
formed to gray colors with ImageJ for 
better visualization. (B) Quantification 
of the percentage of VE-cadherin 
patches showing a significant increase 
in the number of highly active VE-cad-
herin patches and a lower number of 
highly inhibited patches in Casp-8ECKO 
compared with Casp-8WT mice. Each 
box shows the median percentage 
of patches of that type (line) and 
upper and lower quartiles (box). The 
whiskers extend to the most extreme 
data within 1.5 times the interquartile 
range of the box. *P < 0.05; **P < 
0.01, Dirichlet regression model with 
2-tailed Mann-Whitney U test for 
each state. n = 9 WT, n = 9 ECKO. (C) 
Average of the differential distribu-
tion of the percentage of VE-cadherin 
patches in Casp-8WT and Casp-8ECKO 
retinas. Scale bars: 20 μm (A).
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between remodeling (active) and stable (inhibited) VE-cadherin 
patches. As expected, Casp-8WT retinas presented a highly active 
VE-cadherin pattern in the sprouting front that was only slightly 
affected in Casp-8ECKO pups (Supplemental Figure 5, A–C). More 
strikingly, Casp-8ECKO retinas had destabilized, more discontin-
uous (active) VE-cadherin staining in the back (plexus) of the 
retina, whereas Casp-8WT retinas showed continuous (inhibited) 
patches of VE-cadherin (Figure 4, A–C). Analysis of the distribu-
tion of claudin-5 in the plexus, one of the main transmembrane 
proteins found in tight junctions, showed the same discontinuous 
pattern in the back of Casp-8ECKO retinas (Figure 4A).
Next, we confirmed the VE-cadherin phenotype in vitro. 
Consistent with previous studies (42), confluent control shRNA- 
transfected ECs (Casp-8WT ECs) showed a continuous (inhibited) 
VE-cadherin staining along the cell junctions (Figure 5A), which 
became serrated with a rope-ladder pattern (active) upon 30 or 60 
minutes of VEGF stimulation (Figure 5, B and C), as analyzed by 
measuring the average length of individual VE-cadherin patches 
(Figure 5D). In contrast, the distribution of VE-cadherin in confluent 
Casp-8KD ECs was already discontinuous/serrated in unstimu-
lated conditions, and VE-cadherin did not further rearrange upon 
VEGF stimulation (Figure 5, A–D). Moreover, VE-cadherin levels 
at the cell perimeter were reduced under basal conditions (Figure 
5E). However, total VE-cadherin protein levels were unchanged 
(Figure 5F), indicating that VE-cadherin was not degraded, but 
only mislocalized. Taken together, our data show that the absence 
of Casp-8 in ECs affects the proper formation of adherens and 
tight junctions in the postnatal retina as well as the VEGF-induced 
remodeling of VE-cadherin in vitro.
Loss of Casp-8 results in the basal activation of the p38 MAPK. 
We next pursued experiments aimed at identifying the signaling 
pathways involved in EC proliferation, sprouting, and migration 
that could be altered in Casp-8KD ECs. In the absence of Casp-8, 
phosphorylation of Akt, ERK, and FAK was not affected under 
basal conditions or upon VEGF stimulation (Supplemental Figure 
6, A–D). However, knocking down Casp-8 or blocking its activity 
resulted in increased basal p38 MAPK phosphorylation (Figure 6, 
A–C). Still, Casp-8KD ECs or HUVECs treated with ZIETD were 
Figure 5. VE-cadherin distribution in 
ECs is affected in the absence of Casp-8 
in vitro. (A–C) Representative images 
of VE-cadherin (VE-cad) staining in 
confluent HUVECs infected with shCtrl 
or shCasp-8 lentivirus (GFP+) with (B and 
C) or without (A) VEGF (50 ng/ml) stim-
ulation. Results of tracing VE-cadherin 
staining of the single cells within orange 
dotted insets is shown in the adjacent 
right panels. Yellow arrows point to 
empty VE-cadherin spots. (D) Quantifi-
cation of the average length of VE-cad-
herin patches showing that VEGF-in-
duced VE-cadherin reorganization is 
impaired in Casp-8KD ECs. ***P < 0.001, 
2-way ANOVA with Bonferroni’s multiple 
comparisons test. (E) Quantification of 
the total amount of VE-cadherin per 
cell perimeter showing less VE-cadherin 
in Casp-8KD ECs. ***P < 0.001, 2-tailed 
unpaired Student’s t test. (F) Western 
blot showing unchanged total VE-cad-
herin protein levels in HUVECs infected 
with shCtrl or shCasp-8. For D and E, at 
least 15 cells per condition were quan-
tified. n = 3. Data are shown as mean ± 
SEM. Scale bars: 20 μm (A–C).
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
5 0 9 9jci.org   Volume 129   Number 12   December 2019
the cell surface of Casp-8KD ECs was fully recovered (Figure 6F), 
indicating that indeed the basal activation of p38 was linked to VE- 
cadherin localization.
To determine whether the basal increase in p-p38 in Casp-8KD 
ECs was also sufficient to functionally block VEGF-induced 
angiogenesis in Casp-8KD ECs, we performed the tube-formation 
and bead-sprouting assays in the presence of the p38 inhibitor. 
Indeed, inhibition of p38 rescued the ability of Casp-8KD ECs to 
respond to VEGF and to form both tubes (Figure 6G and Supple-
mental Figure 6H) and sprouts (Figure 6H) of a length similar to 
that of Casp-8WT ECs.
able to further activate p38 upon VEGF stimulation (Supplemen-
tal Figure 6, A and E–G). As increased activation of p38 has been 
linked to the destabilization of VE-cadherin in the endothelium 
(43, 44), and as VE-cadherin distribution was already altered in 
basal conditions in Casp-8KD ECs (Figure 5, A and D), we explored 
whether the increased basal levels of phosphorylated p38 (p-p38) 
in Casp-8KD ECs were linked to the changes in the distribution of 
VE-cadherin. For this, we blocked p38 activity in confluent ECs 
with the specific p38 inhibitor SB203580 (45). Even though the 
length of individual surface VE-cadherin patches was only partially 
rescued (Figure 6, D and E), the total amount of VE-cadherin at 
Figure 6. Loss of Casp-8 results in basal activation of p38 MAPK, VE-cadherin instability, and defects in angiogenesis in vitro. (A)Western blots showing 
increased p-p38 under basal conditions in Casp-8KD (shCasp-8) ECs compared with control. (B) Quantification of p-p38 as in A. n = 5. (C) Quantification of 
p-p38 of HUVECs treated with ZIETD (10 μM, 16 hours) under basal conditions, showing that blocking Casp-8 activity also induces increased basal p-p38. n 
= 3. (D) Images of VE-cadherin staining in shCtrl and shCasp-8–infected HUVECs treated with or without p38 inhibitor (SB203580, 1 μM, 16 hours). Yellow 
arrows point to empty VE-cadherin spots. (E) Quantification of VE-cadherin average patch length from cells as in H. (F) Quantification of the total amount of 
VE-cadherin per cell perimeter reveals that inhibition of p38 (SB203580) in Casp-8KD ECs restores VE-cadherin to control levels. At least 15 cells per condition 
were quantified. n = 3. (G) Quantification of total tube length of HUVECs treated as in E showing that blocking p38 in Casp-8KD ECs restores VEGF-induced 
tube formation. 3 fields per condition were quantified. n = 4. (H) Quantitative analysis of total sprout length showing that inhibition of p38 rescues VEGF- 
induced EC sprouting in Casp-8KD ECs. Approximately 20 beads per condition were quantified. n = 3. For B, C, and E–H, data represent mean ± SEM. *P < 
0.05, 1-sample t test (B and C); *P < 0.05; **P < 0.01; ***P < 0.001, 2-way ANOVA with Bonferroni’s multiple comparisons test (E–H). Scale bars: 20 μm (D).
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Activation of p38 MAPK upon loss of Casp-8 is mediated by RIPK3. 
Casp-8 inhibits RIPK3 (12), and it has recently been shown that 
RIPK3 regulates vessel permeability via p38 in ECs (22). Therefore, 
we asked whether RIPK3 could act downstream of Casp-8 to regu-
late p38. Interestingly, we observed that Casp-8KD ECs expressed 
These results indicate that the loss of Casp-8 results in desta-
bilization of EC junctions via an increased basal phosphorylation 
of p38. They also indicate that the increased basal p38 activity is 
responsible for the reduced response to VEGF, resulting in overall 
impaired angiogenesis (see model in Figure 7J).
Figure 7. RIPK3 acts downstream of Casp-8 to regulate angiogenesis. (A) Western blot showing that knocking down RIPK3 in Casp-8KD ECs rescues the 
basal hyperphosphorylation of p38. Notice that shCasp-8 HUVECs have increased RIPK3 protein levels. (B) Quantification of Western blots under basal 
conditions as in A. n = 4. (C) Quantitative PCR (qPCR) of shCtrl or shCasp-8–infected HUVECs showing increased mRNA expression of Ripk3 in the absence 
of Casp-8. n = 4. (D) Quantification of total tube length of shCtrl or shCasp-8–infected HUVECs that were cotransfected with control siRNA or Ripk3 siRNA 
and treated with or without VEGF (50 ng/mL) for 4 hours. Ten fields per condition were quantified. n = 3. (E) BrdU+ cells were quantified in control and Casp-8KD 
ECs transfected with Ripk3 siRNA and with or without VEGF (50 ng/mL) or FGF (50 ng/mL) stimulation for 24 hours. Around 50 cells per condition were 
quantified. n = 3. (F and G) Representative images of the retinal vasculature stained with IsoB4 in Casp-8WT/RIPK3KO and Casp-8ECKO/RIPK3KO mice. (H and I) 
Quantitative analysis showing no differences in vessel area (H; n = 11 WT, n = 7 ECKO) and number of branches (I; n = 9 WT, n = 7 ECKO). Data from 4 indepen-
dent litters. (J) Working model summarizing the role of Casp-8 as a modulator of angiogenesis. Casp-8 inhibits RIPK3 to allow the proper response of ECs to 
VEGF stimulation (Casp-8WT). If Casp-8 is absent (Casp-8ECKO), increased RIPK3 levels induce p38 hyperphosphorylation, which in turn leads to an impaired 
response to VEGF stimulation and reduced angiogenesis. For B–D, E, H, and I, data are shown as mean ± SEM. *P < 0.05; ***P <0.001, 1-sample t test (B and 
C); *P < 0.05; **P < 0.01; ***P < 0.001, 2-way ANOVA with Tukey’s multiple comparisons test (D and E); 2-tailed unpaired Student’s t test (H and I).
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with that in Casp-8KD ECs, as measured by BrdU incorporation 
(Figure 7E).
To confirm the role of RIPK3 in Casp-8ECKO mice in vivo, we 
crossed our Cdh5-(PAC)-CreERT2 × Casp-8fl/fl mice with a RIPK3KO 
mouse line (47). In line with our in vitro results, RIPK3 did not reg-
ulate angiogenesis under physiological conditions, as neither the 
vessel area nor the number of branchpoints (Supplemental Fig-
ure 7, D–G) in the retina of heterozygous or homozygous RIPK3KO 
pups was affected at P6 compared with those of WT littermates. 
In contrast, the vascular defects in Casp-8ECKO mice were rescued 
in Casp-8ECKO/RIPK3KO mice, as the vessel area (Figure 7, F–H) 
and number of branchpoints (Figure 7I) were similar to those of 
Casp-8WT/RIPK3KO mice.
In summary, these results show that, in the absence of Casp-8, 
RIPK3 mediates increased phosphorylation of p38 in vitro and 
impaired developmental vascular growth in vivo. We propose 
higher RIPK3 protein (Figure 7A) and mRNA levels (Figure 7C), 
as was also shown in epithelial Casp-8KO mice (46). To investigate 
whether p38 was activated downstream of RIPK3 in Casp-8KD ECs, 
we additionally knocked down RIPK3 and analyzed p38 phosphor-
ylation. KD of RIPK3 alone had no impact on either basal p-p38 or 
on VEGF-induced p38 phosphorylation (Supplemental Figure 7, A 
and B). However, the basal increase in p-p38 present in Casp-8KD 
ECs was rescued to control levels in Casp-8KD/RIPK3KD ECs (Figure 
7, A and B), indicating that RIPK3 was responsible for the increased 
p-p38 levels observed in Casp-8KD cells.
Consistent with these effects on p-p38, KD of RIPK3 also 
rescued the ability of Casp-8KD ECs to respond to VEGF and to 
form tube-like structures to an extent similar to that seen for 
Casp-8WT and RIPK3KD ECs (Figure 7D and Supplemental Fig-
ure 7C). In addition, proliferation induced by VEGF or FGF 
in Casp-8KDRIPK3KD ECs was also partially rescued compared 
Figure 8. Loss of Casp-8 results in reduced neovascularization in the OIR model. (A) Schematic showing the timeline of the OIR protocol. Pups were 
placed in 75% oxygen (hyperoxia) from P7 to P10, then placed back under normal oxygen conditions (normoxia) until P15. Tamoxifen was injected at 
P10–P12 and P14. (B and C) Representative images of the retinal vasculature stained with IsoB4 in Casp-8WT and Casp-8ECKO mice. Red space indicates the 
avascular area (B), and red outlines indicate neovascular tufts (C). (D and E) Pathological neovascularization is reduced in Casp-8ECKO mice (D) compared 
with Casp-8WT littermates, while the avascular area was higher in Casp-8ECKO mice (n = 16 WT, n = 8 ECKO). (F and G) Retroorbital injection of IsoB4–Alexa 
Fluor 647 did not reveal any difference in vessel perfusion among Casp-8ECKO and Casp-8WT mice (n = 11 WT, n = 10 ECKO), as quantified by measuring Alexa 
Fluor 647 fluorescent intensity in IsoB4–Alexa Fluor 568–labeled vessels. Data are shown as mean ± SEM from 3 independent litters. *P <0.05; ***P < 
0.001, 2-tailed unpaired Student’s t test. Scale bars: 500 μm (B); 250 μm (C); 100 μm (F).
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Finally, to examine vessel integrity and functionality of the 
newly formed vasculature, we analyzed vessel perfusion by retro-
orbital injection of IsoB4–Alexa Fluor 647 (which attaches to the 
vessel lumen and hence, labels perfused vessels), as previously 
described (53, 54). Then the isolated retinas were costained with 
IsoB4–Alexa Fluor 568 to determine the vessel area. Analysis of 
IsoB4–Alexa Fluor 647 per vessel area revealed efficient vessel 
perfusion in both genotypes (Figure 8, F and G).
Taking these data together, we determined that targeting 
Casp-8 in ECs in a model of OIR, resembling ROP, could indeed 
be beneficial, as it reduces the severity of tuft formation without 
compromising the newly formed vasculature.
Discussion
Components of both the intrinsic and extrinsic apoptosis signaling 
pathways have been described as being active in ECs and involved 
in different processes during the formation of the vascular system. 
While the intrinsic pathway of apoptosis (induced by the activation 
of Bax and Bak) is crucial for the regression and cell death of ECs 
from hyaloid vessels in the retina (55–58), this pathway controls EC 
numbers (8, 10, 59–61), but is not an active driver of vessel remod-
eling/pruning in the postnatal retina vasculature. On the other 
hand, activation of the extrinsic signaling machinery via activation 
of CD95 expressed in retinal ECs contributes to vessel develop-
ment by regulating EC proliferation instead of cell death (62).
Casp-8 is a key protease in the extrinsic cell death signaling 
pathway that has both cell death–inducing and prosurvival func-
tions (21). A basal Casp-8 activity is required for cell survival, as 
it inhibits the activation of RIPK3 and thus the subsequent phos-
phorylation of MLKL, leading to necroptosis (63). Under patholog-
ical conditions, tumor-induced EC necroptosis has been described 
as a mechanism via which tumor cells extravasate and metastasize 
(23). However, in the same tumor model, it has also been shown 
that RIPK3 regulates vessel permeability independently of EC 
necroptosis (22). Here, we show that necroptosis is not involved 
in postnatal developmental angiogenesis, as the vascular defects 
in Casp-8ECKO mice are still present in Casp-8ECKO/MLKLKO ret-
inas. Notably, proper angiogenesis was restored in Casp-8ECKO/
RIPK3KO pups, indicating that the vascular impairments in Casp-8ECKO 
mice were mediated by RIPK3, thus assigning a necroptosis- 
independent function for RIPK3 in ECs during angiogenesis.
Cell death–independent functions of Casp-8 have been 
shown to be both activity dependent (16, 64) and independent 
(acting as a scaffold protein; refs. 14, 32). While we do not rule 
out that Casp-8 could also act as a scaffold protein to regulate 
the angiogenic response of ECs, here we show that its activity is 
required. The cellular substrate for Casp-8 in ECs during angio-
genesis has yet to be identified. However, as RIPK3 mRNA levels 
are upregulated in Casp-8KD ECs, which is similar to what occurs 
in epithelial cells without Casp-8 (46), transcriptional regulators 
might be involved.
Mechanistically, Casp-8 deletion in ECs results in EC prolifer-
ation, sprouting, and VE-cadherin subcellular distribution defects. 
Analysis of different signaling pathways revealed that Casp-8KD 
ECs had increased basal activation of p38. Consistent with our 
findings, loss of Casp-8 in the epidermis has also been shown to 
induce the upregulation of p-p38 (65). Despite the fact that VEGF 
that this RIPK3/p-p38 axis deregulates EC behavior, resulting in 
impaired angiogenesis (Figure 7J).
Casp-8ECKO mice show reduced pathological angiogenesis in a model 
of ROP. So far, our results indicate that Casp-8 is required for proper 
developmental angiogenesis and, when absent, EC proliferation, 
migration, and cell junction formation do not occur properly, result-
ing in reduced vessel sprouting and growth. To analyze the impact 
of these vascular defects in Casp-8ECKO mice at later developmental 
stages, we extended our tamoxifen treatment protocol to the first 2 
postnatal weeks and analyzed Casp-8ECKO mice at P15 and P42 (Sup-
plemental Figure 8). At both stages, Casp-8ECKO mice did not show 
differences in the vessel area (Supplemental Figure 8, B and E) or 
number of branches (Supplemental Figure 8, C and F) compared 
with control littermates. In addition, we analyzed vessel integrity by 
injecting 70 kDa fluorescently labeled dextran and could not detect 
any obvious difference in vessel permeability (Supplemental Figure 
8, D and G) between genotypes. Taken together, these data suggest 
that compensatory mechanisms overcome the loss of Casp-8 in ECs 
while mouse development continues.
Despite the better control of oxygen administration to 
preterm infants, ROP persists in extremely low gestational ages 
and birth weights and is still a clinical problem (48). ROP is char-
acterized by 2 phases. In phase 1, exposure of preterm infants to 
high extrauterine oxygen levels causes cessation of vessel growth. 
However, as the metabolic demand of the retina increases over time 
and as there is a lack of proper tissue oxygenation, upregulation 
of VEGF induces pathological neovascularization, consisting of 
extensive extraretinal neovascular tufts in phase 2 of ROP (49). 
As our in vitro data showed that Casp-8KD ECs were not able to 
respond to VEGF, we explored whether the loss of Casp-8 could 
also reduce pathological angiogenesis during ROP. We therefore 
applied the OIR model, which closely resembles the 2 phases of 
ROP (50, 51). In this model, high oxygen levels induce rapid ves-
sel regression, followed by upregulation of VEGF, which causes 
pathological vessel sprouting and formation of abnormal and 
leaky vascular tufts.
For this, we exposed pups to high oxygen levels (75%) to 
induce vessel regression from P7 to P10 (Figure 8A), as previously 
described (35). Subsequently, pups were returned to normoxia 
until P15, causing the now avascular retina to become hypoxic and 
upregulate VEGF, inducing the neovascular response. Cre recom-
bination and Casp-8 deletion were induced on return to normoxia 
from P10 to P14 to evaluate the effect of Casp-8 loss on patholog-
ical neovascularization (Figure 8A). Analysis of the retinal vascu-
lature at P15 showed that pathological neovascularization (quanti-
fied by measuring the neovascular tuft area; ref. 52) was strongly 
reduced in Casp-8ECKO compared with Casp-8WT retinas (Figure 8, 
C and D), supporting the concept that blocking Casp-8 is benefi-
cial for preventing disease progression. In addition to pathologi-
cal neovascularization, normal angiogenesis gradually replaced 
the vessels lost from the central retina following exposure to high 
oxygen. Analysis of the avascular area showed a slight increase in 
Casp-8ECKO pups compared with WT littermates (Figure 8, B and 
E). This result is probably a combination of reduced pathological 
neovascularization and reduced vessel regrowth, consistent with 
our finding that angiogenesis and the response to VEGF were 
reduced in Casp-8KD ECs.
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necroptosis contributes to the increased avascular area observed 
in Casp-8ECKO mice). Nevertheless, based on the fact that under 
physiological conditions, Casp-8ECKO retinas finally achieve a nor-
mal and functional vasculature, we propose that inactivation of 
Casp-8 in ECs during ROP is beneficial, as it will inhibit aberrant 
neovascularization, and in a way similar to that seen in develop-
ment, the avascular area will be finally recovered. Whether targeting 
Casp-8 is also beneficial in an adult setting of ischemic retinop-
athy, such as occurs during proliferative diabetic retinopathy or 
retinal vein occlusion, requires further investigation. Although 
we have shown that the loss of Casp-8 in ECs is compensated 
during development and that Casp-8ECKO mice at P15 and P42 did 
not present vascular defects or increased vessel permeability, we 
cannot rule out that the acute deletion of Casp-8 in ECs in the 
healthy or diseased adult retinal vasculature might have a nega-
tive impact. In addition, even though the results presented in the 
OIR model are encouraging, we acknowledge that further clini-
cal evidence is necessary and should be provided in the future to 
determine whether and how Casp-8 could be locally targeted in 
retina ECs in human patients.
Methods
Please see Supplemental Methods for further experimental procedures.
Mouse lines and treatment. Casp-8fl/fl mice (69) were crossed with 
Cdh5(PAC)-CreERT2 mice (24) to specifically delete Casp-8 in the 
endothelium upon tamoxifen treatment. MLKLKO mice were provided 
by M. Pasparakis (CECAD, University of Cologne, Cologne, Germany). 
RIPK3KO mice (47) were provided by Genentech. Pregnant females 
were i.p. injected with 2 mg tamoxifen/30 g body weight from E8.5 
until E10.5. Embryos were dissected at E13.5 and assessed for heart-
beat (alive), death, or presence of malformations, such as bleedings 
or (cardiac) edema (Supplemental Figure 1B). Recombination in pups 
was induced by intragastric injection of 50 μL tamoxifen (1 mg/mL) at 
P1–P3 and P5 as shown in Figure 1A. For analysis at P15 and P42, pups 
received additional tamoxifen injections (i.p.) at P8, P11, and P14.
OIR model. To induce retinal pathological angiogenesis in Casp-8ECKO 
mice, the OIR model was used, as previously described (35). From P7 
to P10, pups were placed in 75% oxygen (hyperoxia); at P10, pups were 
returned to normal oxygen conditions (normoxia) until P15 (35). Cre 
recombination was induced by i.p. injection of 50 μL tamoxifen (2 mg/
mL) at P10–P12 and P14. To analyze vessel perfusion, pups at P15 were 
retroorbitally injected with IsoB4–Alexa Fluor 647 (5 mg/kg body 
weight), as previously described (54), and sacrificed after 5 minutes. 
Retinas were isolated and fixed in 4% PFA/PBS for 1 hour at room 
temperature (RT). Conditions used for the retina staining are specified 
in the Retina dissection, processing, and staining section. Quantification 
of the size of the avascular area and neovascular tufts was performed 
in Adobe Photoshop with investigators blinded to experimental condi-
tions, as previously described (52). To quantify vessel perfusion, mean 
fluorescent intensity of injected IsoB4–Alexa Fluor 647 was normal-
ized to the intensity of vascular stained with IsoB4–Alexa Fluor 568, as 
previously described (54).
Analysis of EC proliferation in vivo. EdU (Thermo Scientific) was 
injected at a concentration of 100 μg/g body weight into P6 Casp-
8ECKO pups, as previously described (70), 2.5 hours before culling. 
Eyes were fixed in 4%PFA for 1.5 hours at 4°C. EdU+ cells in the retina 
were detected with the Click-iT EdU Alexa Fluor 488 Imaging Kit 
stimulation activated ERK, Akt, FAK, and p38 in Casp-8KD ECs, this 
did not result in a functional angiogenic response in vitro. How-
ever, when p38 activity was blocked, Casp-8KD ECs responded 
normally to VEGF stimulation in the sprouting and tube-forma-
tion assay. These findings indicate that the basal overactivation 
of p38 was already enough to functionally inhibit the response 
of Casp-8KD ECs to VEGF and thus to impair angiogenesis. It was 
previously reported that p38 activity induces EC migration (66). 
However, in our experimental setup, EC migration was not affected 
in Casp-8KD ECs under basal conditions, even though p38 was 
already more highly activated. As migration of Casp-8KD ECs does 
not change under basal conditions, this suggests that p38-inde-
pendent mechanisms might account for this phenotype. We could 
also link RIPK3 to p38 hyperactivation, as in vitro KD of RIPK3 in 
Casp-8KD ECs rescued the basal phosphorylation of p38 to control 
levels. Further studies are needed to investigate how RIPK3 regu-
lates p38 and whether RIPK3 activity is required.
Specific loss of Casp-8 in the epidermis results in increased 
p38 phosphorylation (65) and loss of junction integrity in epithe-
lial cells, independently of cell death (40). Here, we show that 
loss of Casp-8 in ECs in vitro resulted in impaired distribution of 
VE-cadherin at the cell membrane, creating a serrated pattern. 
Moreover, Casp-8KD ECs failed to induce VE-cadherin rearrange-
ments required for proper angiogenesis upon VEGF stimulation. 
This phenotype was rescued when p38 was inhibited in vitro. So 
far, it is not very well understood how p38 regulates VE-cadherin 
localization under physiological conditions. However, tumor tran-
sendothelial cell migration studies suggest that p38 does not act 
directly on VE-cadherin, but rather promotes its internalization 
via the formation of stress fibers (67). We therefore hypothesize 
that the activation of p38 in the absence of Casp-8 could cause the 
VE-cadherin defects via a similar mechanism.
In vivo, VE-cadherin stability was altered at the back of the 
retina of Casp-8ECKO EC pups, suggesting that EC-EC contacts fail 
to stabilize. Recent studies indicate that, rather than its sole pres-
ence or absence (35–37, 39), it is the dynamic and heterogeneous 
expression of VE-cadherin in different areas of the developing ves-
sel sprout that drives angiogenesis (38). Consistent with this cur-
rent view, which suggests that EC junctions in the back of the retina 
have to be stabilized in order to allow proper sprout elongation in 
the front, we postulate that the increased number of vessel patches 
with serrated junctions in the back of Casp-8ECKO retinas blocks EC 
positional interchanges, ultimately resulting in a reduced number 
of sprouts at the vascular front and thus reduced angiogenesis.
ROP in preterm infants is characterized by pathological retina 
neovascularization and excessive extraretinal tuft formation (50, 
68). Here, by applying the OIR model, resembling ROP, we show 
that Casp-8 is mechanistically involved in the pathophysiology of 
developmental neovascular ocular disease. Indeed, Casp-8ECKO 
mice, in which Casp-8 was deleted in ECs just during the neovas-
cularization phase, presented reduced aberrant vascular tufts. 
Consistent with our findings that Casp-8KD ECs have a reduced 
response to VEGF stimulation and thus show reduced VEGF- 
induced angiogenesis, we also observed a slight increase in the 
avascular area, suggesting that the newly regrowing vessels devel-
op more slowly in Casp-8ECKO retinas compared with Casp-8WT 
retinas (however, we cannot exclude that in this specific setting, 
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acquired simultaneously using a Zeiss LSM 800 (×20 objective). 
Bright field images were processed and background corrected with a 
rolling ball algorithm in ImageJ (NIH).
Lung EC isolation. Murine lung ECs were isolated by MACS Tech-
nology (Miltenyi Biotec). Lungs of P6 mouse pups were isolated and 
kept in ice-cold HBSS containing 10% FCS. Tissue from Casp-8WT 
and Casp-8ECKO pups from the same litter were pooled and digested in 
collagenase I/DNAse I (0.1 mg/mL, Roche) at 37°C. The digested tis-
sue was filtered, incubated with Red Blood Cell Lysis Buffer (Roche), 
and washed several times with PEB buffer (0.5% BSA, 2 mM EDTA in 
PBS). Negative selection of CD45+ cells was performed by incubation 
of the cell suspension with CD45 MicroBeads (1:10) for 15 minutes at 
4°C. Cell suspensions were applied onto LS columns, and unlabeled 
cells were collected on ice. Enrichment of ECs was performed using 
CD31 MicroBeads (1:10) in PEB buffer for 15 minutes at 4°C and appli-
cation on MS columns. The positive cell fraction was eluted from the 
columns with PEB buffer and directly frozen in RLT buffer (QIAGEN) 
for RNA isolation.
Analysis of VE-cadherin localization in ECs in vitro. For VE-cadherin 
staining in HUVECs, 1 × 105 infected cells (shCtrl or shCasp-8) were 
seeded and allowed to attach overnight. Cells were starved overnight 
and stimulated with 50 ng/mL VEGF for the indicated time points. 
After fixation in 4% PFA/PBS for 30 minutes at RT and permeabili-
zation in 0.5% Triton X-100/PBS for 10 minutes, blocking in 1% BSA, 
20% normal donkey serum (Dianova) in 0.2% Triton X-100/PBS was 
done for 1 hour at RT. Samples were incubated with primary anti-
body (anti–VE-cadherin, 1:200, catalog 610252, BD Bioscience) for 2 
hours at RT, followed by incubation with the appropriate Alexa Fluor– 
conjugated secondary antibody for 2 hours at RT. Nuclei were counter-
stained with DAPI (1:1000, D1306, Invitrogen). After mounting, ran-
dom fields of view were imaged with a Zeiss LSM 800 (×63 objective). 
VE-cadherin at the cell perimeter of single, nonadjacent cells was 
manually traced with ImageJ. Total VE-cadherin at the cell perimeter 
was calculated as the sum of all individual VE-cadherin patches. At 
least 15 cells per condition were quantified with investigators blinded 
to the experimental condition from 3 independent experiments.
Fibrin gel bead sprouting assay. Fibrin gel bead sprouting assay 
was performed as previously described (72). Briefly, Cytodex 3 micro-
carrier beads (GE Healthcare) were coated with siRNA-transfected or 
shRNA- infected HUVECs (mixed at 200 cells per bead) and embed-
ded in 2 mg/mL fibrin gels (2 mg/mL fibrinogen [Calbiochem], 0.625 
units/mL thrombin [Sigma-Aldrich], and 0.15 units/mL aprotinin 
[Sigma-Aldrich]). Beads were cultured in 2% FBS growth factor–free 
Endopan 3 medium in the presence or absence of 50 ng/ml VEGF. 
After 24 hours, the culture was fixed with 4% PFA for 15 minutes, 
blocked in 1% BSA, 0.2% Triton X-100–PBS, and incubated with 1 
μg/mL phalloidin-fluo (94507, Sigma-Aldrich) for 2 hours. Confocal 
images were taken with a Zeiss LSM 510 microscope and analyzed by 
ImageJ. Quantification was done with investigators blinded to experi-
mental conditions. Approximately 20 beads per condition were quan-
tified from 4 independent experiments.
Single EC tracings. Single EC tracings were performed as previously 
described (33). Infected ECs with shRNA control or shCasp-8 were 
plated on 6-well plates and stimulated with 50 ng/mL VEGF or con-
trol vehicle (after overnight starvation). Phase contrast images of 10 
fields of view per well were acquired every 10 minutes over the course 
of 12 hours using an inverted NikonTi microscope (with a Nikon Plan 
(Thermo Scientific), according to the manufacturer’s instructions. ECs 
were counterstained with ERG and IsoB4. Eight pictures per pup of the 
angiogenic front were imaged at ×20 magnification with an LSM 510 
META. Quantification was done with investigators blinded to exper-
imental conditions. The number of proliferating ECs is expressed as 
EdU+ERG+ cells normalized to the IsoB4+ vessel area per field of view.
Whole-mount staining of the yolk sac vasculature. Yolk sacs were 
fixed overnight in 4% PFA/PBS at 4°C. After permeabilization in 1% 
Triton X-100/PBS for 1 hour at RT and blocking in 0.2% BSA, 5% 
normal donkey serum (Dianova), and 0.3% Triton X-100 in PBS for 2 
hours at RT, primary antibody Endoglin (1:200, MAB1320, R&D Sys-
tems) was incubated overnight at 4°C in blocking solution. The appro-
priate Alexa Fluor–conjugated secondary antibody was incubated 
overnight at 4°C. Whole-mount images were acquired on an LSM 510 
META confocal microscope.
Retina dissection, processing, and staining. Eyes were collected and 
enucleated in PBS. For VE-cadherin staining, eyes were fixed in 2% 
PFA/PBS for 1 hour at 4°C. For all other staining, eyes were fixed for 1.5 
hours in 4% PFA/PBS at 4°C. Retinas were dissected, permeabilized 
with PBS containing 1% BSA and 0.3% Triton X-100 for 1 hour, and 
incubated with primary antibodies at 4°C overnight. Antibodies used 
were as follows: Alexa Fluor 594–conjugated isolectin GS-IB4 (1:250, 
catalog I21413, Thermo Scientific), Casp-8 (1:100, catalog 4927, Cell 
Signaling Technology), ERG (1:200, catalog ab92513, Abcam), colla-
gen IV (1:200, catalog CO20451, BIOZOL), Desmin (1:200, catalog 
ab15200, Abcam), VE-cadherin (1:100, catalog 555289, BD Biosci-
ences), claudin-5 (1:100, catalog 34-1600, Thermo Scientific), and 
cCasp-3 (1:100, catalog 661, Cell Signaling). After washing with PBS, 
retinas were incubated for 2 hours at RT with the respective second-
ary antibody. TUNEL assay (Roche) was performed according to the 
manufacturer’s instructions. Briefly, retinas were fixed for 2 hours 
in 4% PFA/PBS at RT. Permeabilization was done in 0.5% Triton 
X-100/0.1% citrate in PBS for 3 hours at RT. Then labeling of TUNEL+ 
cells was done for 1 hour at 37°C. After washing, samples were stained 
with FITC-conjugated IsoB4 (1:250, ALX-650-001F-MC05, Enzo 
Life Sciences) in 1% BSA, 0.3% Triton X-100/PBS, for 1 hour at RT. 
Retinas were flat mounted and analyzed using a confocal fluorescence 
microscope (LSM 510 META or LSM800; Carl Zeiss).
Analysis of VE-cadherin localization in ECs in vivo. For analysis 
of VE-cadherin in the retina of P6 pups, high-magnification pictures 
(×63) were acquired. Two pictures from either the angiogenic front or 
the back of the retina were randomly taken in areas adjacent either to 
a vein or an artery. Representative inset pictures show the most active 
or inhibited pattern of VE-cadherin in Casp-8WT and Casp-8ECKO pups. 
Quantification of the percentage of VE-cadherin patches was done 
with investigators blinded to experimental conditions using MATLAB 
as previously described (35).
ISH in the retina. ISH was performed with minor modifica-
tions, as previously described (71). In brief, eyes of P6 pups were 
removed and fixed for 20 minutes in 4% PFA on ice. After isolation 
and dissection, retinas were stored in methanol at –20°C overnight. 
Hybridization was performed at 66°C. Primer sequences to gener-
ate probes to detect mouse Casp-8 were as follows: Casp-8, forward: 
3′-TTTCCACATCAGTCGGTGGG-5′; Casp-8, reverse: 3′-CTCTTG-
GCGAGTCACACAGT-5′. After color development, retinas were 
extensively washed with PBS and counterstained with Alexa Fluor 
594– conjugated IsoB4. Bright field and fluorescent images were 
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To calculate statistical significance for Figure 4 (analysis of 
VE-cadherin distribution in vivo), the Dirichlet regression model was 
applied for the analysis of binned data. Additional Mann- Whitney 
U tests for each state are reported to indicate states with strong 
differences between groups. All calculations were performed 
using Prism software. A P value of less than or equal to 0.05 was 
considered significant.
Study approval. All animal procedures were conducted in accor-
dance with European, national, and institutional guidelines. Protocols 
were approved by local government authorities (Regierungspräsidium 
Karlsruhe, Germany).
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Fluor ×10 NA 0.3 objective) equipped with an environmental box from 
Oko Lab for temperature, CO2, and humidity control. EC migration 
was traced automatically using NIS Elements 4.5 software. At least 30 
cells per condition were quantified with investigators blinded to exper-
imental conditions from 3 independent experiments.
Tube formation. Tube-formation assays were performed in μ-Slide 
Angiogenesis wells (ibidi GmbH) as previously described (33, 73) using 
10 μL of growth factor–reduced Matrigel (BD Biosciences) per well. In 
brief, siRNA-transfected or lentivirus-infected HUVECs resuspended 
in 2% FBS growth factor–free Endopan 3 medium, with or without 
VEGF (50 ng/mL), were seeded onto the polymerized Matrigel. Wher-
ever indicated, prior to seeding on Matrigel, cells were pretreated 
overnight with SB203580 (1 μM). Cells were incubated for 4 hours in 
a humidified chamber at 37°C, 5% CO2 before analysis. Images were 
acquired with a wide-field microscope (Zeiss Axiovert 200) equipped 
with an Axiocam MRm camera and a ×5 objective. At least 3 fields of 
view per condition were acquired. Quantification of 3 independent 
experiments was done with investigators blinded to experimental con-
ditions using the Angiogenesis analyzer tool of ImageJ.
Scratch assay. siRNA-transfected HUVECs were seeded in a 
6-well plate. When cells were confluent, they were starved in 2% 
FBS growth factor–free Endopan 3 medium overnight. A wound was 
induced by scraping the cell monolayer with a P200 pipette tip, and 
cells were stimulated with or without VEGF (50 ng/mL). A picture was 
acquired at time-point zero and 12 hours after incubation at 37°C. The 
percentage of wound closure between 0 hours and 12 hours of VEGF 
stimulation was analyzed with ImageJ with investigators blinded to 
experimental conditions. Results are from at least 3 independent 
experiments. For each treatment, 8 to 10 fields of view were analyzed.
In vitro cell death assay. Infected HUVECs (1 × 105 cells/well in 
6-well plates) were treated with TNF-α (100 ng/mL, Preprotech) and 
TRAIL (100 ng/mL, made in house) in normoxia or hypoxia (0,1% 
O2, BioSpherix, X2, Exvivo System) during 24 hours. After treatment, 
cells were washed with PBS and stained with PI (40 μg/ml) while being 
treated with RNase (100 μg/ml). Quantitative analysis of PI+ cells was 
carried out in a FACSCalibur cytometer using Cell Quest software (BD).
Casp-8 Glo assay. The Casp-8 Glo assay was performed in combina-
tion with the CellTiter-Fluor Cell Viability Assay (both from Promega) 
according to the manufacturer’s instructions. In brief, 6 × 103 HUVECs 
per well were seeded in a 96-well plate. After overnight starvation, cells 
were treated with Z-IETD-FMK (10 μM) or TNF (100 ng/mL) + CHX 
(10 μg/mL) for 4 hours before cell viability and Casp-8 activity were 
measured. Data are expressed as relative units (RU) resulting from the 
Casp-8 Glo (relative luminescent units [RLU])/cell viability (relative 
fluorescence units [RFU]) ratio.
Statistics. Results are expressed as mean ± SEM. To calculate 
statistical significance, 2-tailed Student’s t test, 1-sample t test, 
1-way ANOVA, or 2-way ANOVA followed by Bonferroni’s multi-
ple comparisons test was used, as indicated in the figure legends. 
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